Hochberg Abraham 4
4 · BIOCANCELL THERAPEUTICS INC. · Filed Mar 28, 2012
Insider Transaction Report
Form 4
BIOCANCELL THERAPEUTICS INC.BICL.TA
Hochberg Abraham
DirectorChief Scientist10% Owner
Transactions
- Award
Employee Options
2011-09-27+60,000→ 180,000 totalExp: 2021-09-27→ Common Stock (60,000 underlying) - Award
Employee Options
2012-02-12+300,000→ 480,000 totalExp: 2022-02-12→ Common Stock (300,000 underlying)
Footnotes (4)
- [F1]The exercise price is 2.85 NIS per share.
- [F2]3,750 options shall vest and be exercisable at the end of each calendar quarter, from June 30, 2010 until all options are vested or until vesting is terminated in accordance with the terms of the options.
- [F3]The exercise price is 1.583 NIS per share.
- [F4]18,750 options shall vest and be exercisable at the end of each calendar quarter, from December 31, 2011 until all options are vested or until vesting is terminated in accordance with the terms of the options.